Pituitary apoplexy pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) |
No edit summary |
||
| (50 intermediate revisions by 6 users not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Pituitary | Pituitary apoplexy is an acute [[clinical]] [[syndrome]] caused by [[hemorrhage]] and [[necrosis]] in the [[pituitary gland]]. Most commonly, pituitary apoplexy is associated with [[pituitary adenoma]]. [[Pituitary adenoma]] predisposes the patient to an increased risk of [[bleeding]] within the [[pituitary gland]]. [[Pituitary adenoma]] has [[Fenestrated membrane|fenestrated]] [[endothelium]] surrounded by a variable number of [[smooth muscle cells]] which are not found in the normal [[pituitary gland]], leading to increased susceptibility to pituitary apoplexy in these [[tumors]]. Pituitary apoplexy can result from a [[mutation]] in [[AIP (gene)|AIP gene]] which is a [[tumor suppressor gene]] located on [[chromosome]] 11q13.2. On gross pathology, pituitary apoplexy presents with [[hemorrhage]] with or without [[necrosis]]. [[Electron microscopy]] shows evidence of abnormal [[fenestration]] of tumor [[vessels]] ([[pituitary adenoma]]) with fragmented [[basal membrane]]<nowiki/>s that may predispose the patient to [[hemorrhage]]. | ||
==Pathophysiology== | ==Pathophysiology== | ||
Pituitary | Pituitary apoplexy is caused by bleeding into the [[pituitary gland]]. Most often, pituitary apoplexy is seen with a [[pituitary adenoma]]. [[Pituitary adenoma]] predisposes the patient to an increased risk of [[bleeding]] within the [[pituitary gland]].<ref name="pmid16487443">{{cite journal |vauthors=Nielsen EH, Lindholm J, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P |title=Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma |journal=Clin. Endocrinol. (Oxf) |volume=64 |issue=3 |pages=319–22 |year=2006 |pmid=16487443 |doi=10.1111/j.1365-2265.2006.02463.x |url=}}</ref><ref name="pmid12577104">{{cite journal |vauthors=Chacko AG, Chacko G, Seshadri MS, Chandy MJ |title=Hemorrhagic necrosis of pituitary adenomas |journal=Neurol India |volume=50 |issue=4 |pages=490–3 |year=2002 |pmid=12577104 |doi= |url=}}</ref><ref name="pmid15531524">{{cite journal| author=Zayour DH, Selman WR, Arafah BM| title=Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function. | journal=J Clin Endocrinol Metab | year= 2004 | volume= 89 | issue= 11 | pages= 5649-54 | pmid=15531524 | doi=10.1210/jc.2004-0884 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15531524 }} </ref><ref name="pmid25859802">{{cite journal| author=Oldfield EH, Merrill MJ| title=Apoplexy of pituitary adenomas: the perfect storm. | journal=J Neurosurg | year= 2015 | volume= 122 | issue= 6 | pages= 1444-9 | pmid=25859802 | doi=10.3171/2014.10.JNS141720 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25859802 }} </ref><ref name="pmid5055626">{{cite journal| author=Schechter J| title=Ultrastructural changes in the capillary bed of human pituitary tumors. | journal=Am J Pathol | year= 1972 | volume= 67 | issue= 1 | pages= 109-26 | pmid=5055626 | doi= | pmc=2032586 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5055626 }} </ref><ref name="pmid3417848">{{cite journal| author=Schechter J, Goldsmith P, Wilson C, Weiner R| title=Morphological evidence for the presence of arteries in human prolactinomas. | journal=J Clin Endocrinol Metab | year= 1988 | volume= 67 | issue= 4 | pages= 713-9 | pmid=3417848 | doi=10.1210/jcem-67-4-713 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3417848 }} </ref><ref name="pmid18372348">{{cite journal |vauthors=Nawar RN, AbdelMannan D, Selman WR, Arafah BM |title=Pituitary tumor apoplexy: a review |journal=J Intensive Care Med |volume=23 |issue=2 |pages=75–90 |year=2008 |pmid=18372348 |doi=10.1177/0885066607312992 |url=}}</ref><ref name="pmid6256408">{{cite journal |vauthors=Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, Forsham PH |title=Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma |journal=J. Clin. Endocrinol. Metab. |volume=52 |issue=1 |pages=95–7 |year=1981 |pmid=6256408 |doi=10.1210/jcem-52-1-95 |url=}}</ref> | ||
* [[Pituitary adenomas|Pituitary adenoma<nowiki/>s]] have decreased [[blood]] supply and [[angiogenesis]]. | |||
* A [[pituitary adenoma]] has [[Fenestrated membrane|fenestrated]] [[endothelium]] surrounded by a variable number of [[smooth muscle cells]], which are not found in the normal [[pituitary gland]]. | |||
* [[Vascular endothelial growth factor|VEGF]] [[Messenger RNA|mRNA]] may be increased in [[pituitary tumors]], especially in non-functioning [[pituitary adenomas]], which could be related to an abnormal [[vascularity]]. | |||
* Enlarging [[pituitary adenoma|pituitary adenomas]] may outgrow their [[blood]] supply, making them susceptible to [[bleeding]] and [[infarction]]. | |||
* The [[bleeding]] may lead to increase in [[intrasellar]] [[pressure]]. The increased [[intrasellar]] [[pressure]] may compress the adjoining structures and lead to the clinical [[symptoms]] of pituitary apoplexy. | |||
** An enlarged [[Pituitary adenoma|pituitary tumor]] may become impacted at the diaphragmatic notch, leading to compression of the [[Hypophysis|hypophyseal]] stalk and its [[vascular]] supply. | |||
** This may render the anterior [[pituitary gland]] and its [[tumor]] with reduced [[blood]] supply causing [[ischemia]] and subsequent [[necrosis]]. | |||
** [[Reperfusion]] after [[infarction]] may lead to [[hemorrhage]] within the [[pituitary gland]] or [[Pituitary adenoma|adenoma]]. | |||
==Genetics== | ==Genetics== | ||
*Gene involved in the pathogenesis of pituitary apoplexy include [[mutation]] in AIP gene, which is located on [[chromosome]] 11q13.2 | *[[Gene]] involved in the [[pathogenesis]] of pituitary apoplexy include a [[mutation]] in [[AIP (gene)|AIP gene]], which is located on [[chromosome]] 11q13.2. | ||
*The most common mutation site in AIP gene is p.R304 locus. | *The most common [[mutation]] site in the AIP gene is p.R304 locus. | ||
*Mutated AIP loses its activity as a tumor | *[[Mutated]] AIP loses its activity as a [[Tumor suppressor gene|tumor suppressor gene]] and leads to increased [[Cell (biology)|cell]] [[proliferation]]. | ||
*The penetration of AIP | *The penetration of AIP positive carriers is 12-30%. | ||
==Associated Conditions== | ==Associated Conditions== | ||
Pituitary apoplexy is seen with 0.6 to 10% of pituitary adenomas. | Pituitary apoplexy is seen with 0.6 to 10% of [[Pituitary adenoma|pituitary adenomas]]. | ||
==Gross Pathology== | ==Gross Pathology== | ||
*The predominant finding is hemorrhage with or without necrosis. | *The predominant finding is [[hemorrhage]] with or without [[necrosis]]. | ||
*Pale, necrotic material | *Pale, [[necrotic]] material is particularly found when there is a long interval between the acute clinical event and [[surgery]]. | ||
[[ | ==Microscopic Pathology== | ||
[[Electron microscopy|Electron microscopic]] shows evidence of abnormal [[fenestration]] of [[tumor]] [[vessels]] ([[pituitary adenoma]]) with fragmented [[basal membrane]]<nowiki/>s that may predispose the patient to [[hemorrhage]]. | |||
[[File: | [[File:Webp.net-resizeimage.jpg|center|Histopathological image of nonfunctioning pituitary adenoma. Hematoxylin & eosin stain showing basophilic appearance of the cells. Source: By Jensflorian (Own work) [CC BY-SA 3.0 (<nowiki>http://creativecommons.org/licenses/by-sa/3.0</nowiki>)], via Wikimedia Commons |alt=Histopathological image of nonfunctioning pituitary adenoma. Hematoxylin & eosin stain showing basophilic appearance of the cells.|frame]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 16:21, 18 October 2017
|
Pituitary apoplexy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pituitary apoplexy pathophysiology On the Web |
|
American Roentgen Ray Society Images of Pituitary apoplexy pathophysiology |
|
Risk calculators and risk factors for Pituitary apoplexy pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
Pituitary apoplexy is an acute clinical syndrome caused by hemorrhage and necrosis in the pituitary gland. Most commonly, pituitary apoplexy is associated with pituitary adenoma. Pituitary adenoma predisposes the patient to an increased risk of bleeding within the pituitary gland. Pituitary adenoma has fenestrated endothelium surrounded by a variable number of smooth muscle cells which are not found in the normal pituitary gland, leading to increased susceptibility to pituitary apoplexy in these tumors. Pituitary apoplexy can result from a mutation in AIP gene which is a tumor suppressor gene located on chromosome 11q13.2. On gross pathology, pituitary apoplexy presents with hemorrhage with or without necrosis. Electron microscopy shows evidence of abnormal fenestration of tumor vessels (pituitary adenoma) with fragmented basal membranes that may predispose the patient to hemorrhage.
Pathophysiology
Pituitary apoplexy is caused by bleeding into the pituitary gland. Most often, pituitary apoplexy is seen with a pituitary adenoma. Pituitary adenoma predisposes the patient to an increased risk of bleeding within the pituitary gland.[1][2][3][4][5][6][7][8]
- Pituitary adenomas have decreased blood supply and angiogenesis.
- A pituitary adenoma has fenestrated endothelium surrounded by a variable number of smooth muscle cells, which are not found in the normal pituitary gland.
- VEGF mRNA may be increased in pituitary tumors, especially in non-functioning pituitary adenomas, which could be related to an abnormal vascularity.
- Enlarging pituitary adenomas may outgrow their blood supply, making them susceptible to bleeding and infarction.
- The bleeding may lead to increase in intrasellar pressure. The increased intrasellar pressure may compress the adjoining structures and lead to the clinical symptoms of pituitary apoplexy.
- An enlarged pituitary tumor may become impacted at the diaphragmatic notch, leading to compression of the hypophyseal stalk and its vascular supply.
- This may render the anterior pituitary gland and its tumor with reduced blood supply causing ischemia and subsequent necrosis.
- Reperfusion after infarction may lead to hemorrhage within the pituitary gland or adenoma.
Genetics
- Gene involved in the pathogenesis of pituitary apoplexy include a mutation in AIP gene, which is located on chromosome 11q13.2.
- The most common mutation site in the AIP gene is p.R304 locus.
- Mutated AIP loses its activity as a tumor suppressor gene and leads to increased cell proliferation.
- The penetration of AIP positive carriers is 12-30%.
Associated Conditions
Pituitary apoplexy is seen with 0.6 to 10% of pituitary adenomas.
Gross Pathology
- The predominant finding is hemorrhage with or without necrosis.
- Pale, necrotic material is particularly found when there is a long interval between the acute clinical event and surgery.
Microscopic Pathology
Electron microscopic shows evidence of abnormal fenestration of tumor vessels (pituitary adenoma) with fragmented basal membranes that may predispose the patient to hemorrhage.
References
- ↑ Nielsen EH, Lindholm J, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P (2006). "Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma". Clin. Endocrinol. (Oxf). 64 (3): 319–22. doi:10.1111/j.1365-2265.2006.02463.x. PMID 16487443.
- ↑ Chacko AG, Chacko G, Seshadri MS, Chandy MJ (2002). "Hemorrhagic necrosis of pituitary adenomas". Neurol India. 50 (4): 490–3. PMID 12577104.
- ↑ Zayour DH, Selman WR, Arafah BM (2004). "Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function". J Clin Endocrinol Metab. 89 (11): 5649–54. doi:10.1210/jc.2004-0884. PMID 15531524.
- ↑ Oldfield EH, Merrill MJ (2015). "Apoplexy of pituitary adenomas: the perfect storm". J Neurosurg. 122 (6): 1444–9. doi:10.3171/2014.10.JNS141720. PMID 25859802.
- ↑ Schechter J (1972). "Ultrastructural changes in the capillary bed of human pituitary tumors". Am J Pathol. 67 (1): 109–26. PMC 2032586. PMID 5055626.
- ↑ Schechter J, Goldsmith P, Wilson C, Weiner R (1988). "Morphological evidence for the presence of arteries in human prolactinomas". J Clin Endocrinol Metab. 67 (4): 713–9. doi:10.1210/jcem-67-4-713. PMID 3417848.
- ↑ Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008). "Pituitary tumor apoplexy: a review". J Intensive Care Med. 23 (2): 75–90. doi:10.1177/0885066607312992. PMID 18372348.
- ↑ Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, Forsham PH (1981). "Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma". J. Clin. Endocrinol. Metab. 52 (1): 95–7. doi:10.1210/jcem-52-1-95. PMID 6256408.